Methods for assessing the prognosis of a patient with a neurodeg

Details Methods for assessing the prognosis of a patient with a neurodeg Methods for assessing the prognosis of a patient with a neurodeg

1996-12-16

2000-02-08

Scheiner, Laurie

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C12Q 100

Patent

active

060226838

ABSTRACT:
The present invention provides a method for the determining the appropriate therapy and/or prognosis for a patient diagnosed with a non-Alzheimer's disease (AD) neurological disease based upon the patient's apoE allele load. The invention also provides a method for the identification of human subjects with a non-AD neurological disease that are likely to respond in clinical trials that test pharmaceuticals useful in the treatment of neurological diseases.

REFERENCES:
patent: 5508167 (1996-04-01), Roses et al.
Farlow et al., 1996, "Apolipoprotein E Genotype and Gender Influence Response to Tacrine Therapy", Ann. N.Y. Acad. Sci. 802:101-110.
Timchenko et al., 1996, "Trinucleotide repeat disorders in humans: discussions of mechanisms and medical issues", FASEB J. 10:1589-1597.
Salvatore et al., 1995, "Apolipoprotein E in sporadic and familial Creutzfeldt-Jakob disease" Neurosci. Letters 199:95-98.
Brouillet et al., 1995, "Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates", Proc. Natl. Acad. Sci. USA 92:7105-7109.
Hardy et al., Alzheimer's Disease Collaborative Group, "Apolipoprotein Genotype E and Alzheimer's Disease", Lancet 342:737-738, 1993.
Bartus et al., "The Cholinergic Hypothesis of Geriatric Memory Dysfunction", Science 217:408-417.
Bertrand et al., "Association of Apolipoprotein E Genotype with Brain Levels of Apolipoprotein E and Apolipoprotein J(clusterin) in Alzheimer's, Disease", Mol. Brain Res. 33:174-178, 1995.
Boyle et al., "Apolipoprotein E Associated with Astrocytic Glia of the Central Nervous System and With Non Myelinating Glia of the Peripheral Nervous System", J. Clin. Invest. 76:1501-1513, 1985.
Corder et al., "Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families", Science 261:921-923, 1993.
Goodrum, "Cholesterol Synthesis is Down-Regulated During Regeneration of Peripheral Nerve", J. Neurochem 54:1709-1715, 1990.
Koo et al., "Obligatory Role of Cholesterol and Apolipoprotein E in the Formation of Large Cholesterol-Enriched and Receptor Active High Density Lipoproteins", J. Biol. Chem 260:11934-11943, 1985.
Leblanc et al., "Regulation of Apolipoprotein E Gene Expression After Injury of the Rat Sciatic Nerve", J. Neurosis. Res. 25:162-171, 1990.
Masliah et al., "Neurodegeneration in the Central Nervous System of apoE-Deficient Mice", Exp. Neurol. 136:107-122, 1995.
Masliah et al., "Apolipoprotein E Role In Maintaining the Integrity of the Aging Central Nervous System in: Apolipoprotein E and Alzheimer's Disease", Springer-Verlag, Heidelberg pp. 59-73, 1996.
Nalbantoglu et al., "Predictive Value of Apolipoprotein E Genotyping in Alzheimer's Disease . . . ", Ann. Neurol. 36:889-895, 1994.
Noguchi et al., "Apolipoprotein E and Alzheimer's Disease", Lancet (letter) 342:737, 1993.
Payami et al., "Apolipoprotein E and Alzheimer's Disease", Lancet (letter) 342:738, 1993.
Poirier et al., "Apolipoprotein E Allele As a Predictor of Cholinergic Deficits and Treatment Outcome in Alzheimer's Disease", Proc. Natl. Acad. Act. 92:12260-12264, 1995.
Poirier et al., "Cholesterol Synthesis and Lipoprotein Reuptake During Synaptic Remodelling in Hippocampus in Adult Rats", Neuroscience 55:81-90, 1993.
Poirier et al., "Apolipoprotein E Polymorphism and Alzheimer's Disease", Lancet 342:697-699, 1993.
Poirier et al., "Apolipoprotein E, Cholinergic Integrity and Synaptic Plasticity in Alzheimer's Disease in: Apolipoprotein E and Alzheimer's Disease", Springer-Verlag, Heidelberg pp. 22-32, 1996.
Poirier et al., "Astrocytic Apolipoprotein E mRNA and GFAP mRNA in Hippocampus After Entorhinal Cortex Lesioning", Mol. Brain Res. 11:97-106, 1991.
Poirier et al., "Cloning of Hippocampal poly(A) RNA Sequences that Increase After Emtorhinal Cortex Lesion in Adult Rat", Mol. Brain Res. 9:191-195, 191.
Reed et al., "Lower Cognitive Performance in Normal Older Adult Male Twins Carrying the Apolipoprotein E Epsilon 4 Allele", Arch Neurol. 51:1189-1192, 1994.
Rothe et al., "Uptake of Endoneurial Lipoprotein Into Schwann Cells and Sensory Neurons is Mediated by Low Density Lipoprotein Receptors and Stimulated After Axonal Injury", J. Neurochem. 57:2016-2025, 1991.
Schellenberg et al., "Genetic Analysis of Familial Alzheimer's Disease", Neurobiol. Aging 17:149, 1996.

Affiliated with

Also associated with

Rating

Methods for assessing the prognosis of a patient with a neurodeg does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for assessing the prognosis of a patient with a neurodeg, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for assessing the prognosis of a patient with a neurodeg will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1679869